A research study from Queen's University Belfast, in collaboration with University College Dublin, University College London and Cass Business School, has found that babies who were breastfed went on to have a higher household ...
1
0
Being high in 'neuroticism' and low in 'conscientiousness' can come at a cost in terms of income a new study has found. These effects were particularly strong for women, who benefited more than men for being conscientious ...
21
1
Five days unpaid family violence leave is a significant improvement over no guaranteed leave at all. But research shows that finances and domestic violence are inextricably linked.
4
0
French pharmaceuticals giant Sanofi said Wednesday that cost-cutting measures and the strong performance of its rare diseases business drove up profits last year.
0
0
UnitedHealth Group closed 2015 with a 19 percent drop in fourth-quarter profit, but the nation's largest health insurer still topped Wall Street's expectations thanks in part to growth outside of its core insurance business.
0
0
Pfizer Inc., finally turning the corner after years of generic competition that slashed revenue from the drugmaker's former blockbusters, easily beat Wall Street expectations for the third quarter and raised its 2015 earnings ...
3
0
Drugmaker Actavis is planning to change its name as it draws closer to finishing another big deal, the $66 billion purchase of Botox maker Allergan that it announced last fall.
2
0
Drugmaker Merck & Co.'s fourth-quarter profit skyrocketed to $7.32 billion, skewed by an $11.2 billion gain from selling its consumer health business to Germany's Bayer AG.
3
0
Households affected by leprosy face being pushed further into poverty as a result of loss of earnings and treatment costs, according to the first ever study of the economic burden of a common complication of the disease.
13
0
French drugmaker Sanofi sacked its CEO Wednesday following a board room rift over his way of handling one of France's largest publicly traded companies.
0
0
